You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Medtronic
McKesson
Colorcon
Mallinckrodt

Last Updated: April 6, 2020

DrugPatentWatch Database Preview

Zydus Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ZYDUS, and what generic and branded alternatives to ZYDUS drugs are available?

ZYDUS has two hundred and twelve approved drugs.

There are nineteen tentative approvals on ZYDUS drugs.

Summary for Zydus
US Patents:0
Tradenames:180
Ingredients:179
NDAs:212
Patent Litigation for Zydus: See patent lawsuits for Zydus

Drugs and US Patents for Zydus

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc CARVEDILOL carvedilol TABLET;ORAL 077614-004 Sep 5, 2007 AB RX No No   Start Trial   Start Trial
Zydus Pharms MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 203553-001 Nov 16, 2017 AB RX No No   Start Trial   Start Trial
Zydus Pharms Usa Inc GLIPIZIDE AND METFORMIN HYDROCHLORIDE glipizide; metformin hydrochloride TABLET;ORAL 078905-003 Jan 31, 2011 AB RX No No   Start Trial   Start Trial
Zydus Pharms CANDESARTAN CILEXETIL candesartan cilexetil TABLET;ORAL 091390-002 Aug 23, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ZYDUS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
AstraZeneca
Baxter
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.